JUL 02, 2020 2:00 PM SGT

Applications of CytoMicroarrays

Speaker

Abstract

Genomic imbalances or copy number variations (CNVs) are a major cause of pregnancy losses, fetal anomalies identified during prenatal period, congenital defects in newborn, dysmorphology and developmental delay in infants, autism spectrum disorders and mental retardation. Routine karyotyping at 550 band resolution is limited to identifying aneuploidy and large structural anomalies such as chromosomal inversions, deletions and duplications larger than 5 Mb through microscopy and image analysis. Fluorescent in situ hybridization (FISH) testing can useful in detection of smaller genomic imbalances only when the clinical diagnosis is clear and narrowed down to a single condition. CytoMicroarrays can overcome these problems and can identify sub-microscopic microdeletions and duplications of >25 KB size in addition to offering differential diagnosis. Several international bodies including ACMG recommend CytoMicroarray as first tier test for congenital anomalies, developmental delay and autism disorders. The SNP backbone of the cytomicroarray facilitates identification of LOH (Loss of heterozygosity) and UPD (Uni parental disomy) along with CNVs. Limitations of CytoMicroarray include inability to detect CNVs of >25Kb, low level mosaicism of <20% and balanced translocations. The lecture presents 2yr lab experience with a set of case results to demonstrate sensitivity of Cytomicroarray in identification of genomic imbalances along with phenotypic correlation.


Show Resources
You May Also Like
NOV 30, 2021 10:00 AM PST
C.E. CREDITS
NOV 30, 2021 10:00 AM PST
Date: November 30, 2021 Time: 10:00am (PDT), 1:00pm (EDT) The prevalence of thyroid disease worldwide has served as a catalyst for healthcare providers to study various tools and methods to...
DEC 09, 2021 11:00 AM PST
C.E. CREDITS
DEC 09, 2021 11:00 AM PST
Date: December 09, 2021 Time: 11:00am (PDT), 2:00pm (EDT) The burden of antimicrobial resistance (AMR) has been acknowledged worldwide by leading health institutes. Besides the need for new...
DEC 01, 2021 7:00 AM PST
C.E. CREDITS
DEC 01, 2021 7:00 AM PST
Date: December 01, 2021 Time: 7:00am (PST), 10:00am (EST) In the era of immuno-oncology, there is a growing need for the identification of new biomarkers predictive for sensitivity to anti-P...
FEB 24, 2022 10:00 AM PST
C.E. CREDITS
FEB 24, 2022 10:00 AM PST
Date: February 24, 2021 Time: 10:00am (PST), 1:00pm (EST) One of the largest global public health crises is the rise of antimicrobial-resistant infections. Globally, over 700,000 people die...
MAR 23, 2022 11:00 AM PDT
MAR 23, 2022 11:00 AM PDT
Date: March 23, 2021 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEDT) In this presentation, Dr. Middleton will review the development and deployment of large-scale saliva-based COVID-19 test...
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
Loading Comments...
Show Resources